Last edition
News about "Mitigare Capsules"
Granules India Limited Gets ANDA Approval for Colchicine Capsules
Granules India Ltd. has declared that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA), filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company, for Colchicine Capsules, 0.6 mg.
Mitigare Capsules | 02/05/2024 | By Aishwarya | 311
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members